These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12923675)

  • 1. [Glutamate antagonists for treatment of neuropathic pain].
    Block F; Habermeyer B
    Schmerz; 2003 Aug; 17(4):261-7. PubMed ID: 12923675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [NMDA receptor antagonists: a new treatment for neuropathic pain].
    Pud D; Eisenberg E
    Harefuah; 1999 Apr; 136(7):564-7. PubMed ID: 15532603
    [No Abstract]   [Full Text] [Related]  

  • 3. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current approaches with the glutamatergic system as targets in the treatment of neuropathic pain.
    Yogeeswari P; Semwal A; Mishra R; Sriram D
    Expert Opin Ther Targets; 2009 Aug; 13(8):925-43. PubMed ID: 19538098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMDA receptor antagonists for the treatment of neuropathic pain.
    Collins S; Sigtermans MJ; Dahan A; Zuurmond WW; Perez RS
    Pain Med; 2010 Nov; 11(11):1726-42. PubMed ID: 21044263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [NMDA-receptor antagonist in pain therapy].
    Weber C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Aug; 33(8):475-83. PubMed ID: 9746842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
    Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
    Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Memantine and Complex Regional Pain Syndrome (CRPS): effects of treatment and cortical reorganisation].
    Sinis N; Birbaumer N; Schwarz A; Gustin S; Unertl K; Schaller HE; Haerle M
    Handchir Mikrochir Plast Chir; 2006 Jun; 38(3):164-71. PubMed ID: 16883501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome.
    Nisijima K; Shioda K; Yoshino T; Takano K; Kato S
    Pharmacopsychiatry; 2004 Mar; 37(2):57-62. PubMed ID: 15048612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiallodynic effects of NMDA glycine(B) antagonists in neuropathic pain: possible peripheral mechanisms.
    Christoph T; Reissmüller E; Schiene K; Englberger W; Chizh BA
    Brain Res; 2005 Jun; 1048(1-2):218-27. PubMed ID: 15922311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low doses of dextromethorphan have a beneficial effect in the treatment of neuropathic pain.
    Morel V; Pickering G; Etienne M; Dupuis A; Privat AM; Chalus M; Eschalier A; Daulhac L
    Fundam Clin Pharmacol; 2014 Dec; 28(6):671-80. PubMed ID: 24702319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of a multicenter randomized clinical trial with memantine and dextromethorphan in ketamine-responder patients.
    Pickering G; Pereira B; Morel V; Tiberghien F; Martin E; Marcaillou F; Picard P; Delage N; de Montgazon G; Sorel M; Roux D; Dubray C
    Contemp Clin Trials; 2014 Jul; 38(2):314-20. PubMed ID: 24948402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain.
    Medvedev IO; Malyshkin AA; Belozertseva IV; Sukhotina IA; Sevostianova NY; Aliev K; Zvartau EE; Parsons CG; Danysz W; Bespalov AY
    Neuropharmacology; 2004 Aug; 47(2):175-83. PubMed ID: 15223296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of memantine.
    Johnson JW; Kotermanski SE
    Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuropathic pain. Physiopathological mechanisms and therapeutic perspectives].
    Hamon M; Kayser V; Bourgoin S
    Bull Acad Natl Med; 2008 May; 192(5):921-6; discussion 926-8. PubMed ID: 19238782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.
    Sang CN
    J Pain Symptom Manage; 2000 Jan; 19(1 Suppl):S21-5. PubMed ID: 10687335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memantine treatment of complex regional pain syndrome: a preliminary report of six cases.
    Sinis N; Birbaumer N; Gustin S; Schwarz A; Bredanger S; Becker ST; Unertl K; Schaller HE; Haerle M
    Clin J Pain; 2007; 23(3):237-43. PubMed ID: 17314583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic N-methyl-D-aspartate receptor antagonists: will reality meet expectation?
    Smith PF
    Curr Opin Investig Drugs; 2003 Jul; 4(7):826-32. PubMed ID: 14619404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA receptor antagonists: tools in neuroscience with promise for treating CNS pathologies.
    Köhr G
    J Physiol; 2007 May; 581(Pt 1):1-2. PubMed ID: 17331982
    [No Abstract]   [Full Text] [Related]  

  • 20. Alzheimer's disease and the glutamate NMDA receptor.
    Doraiswamy PM
    Psychopharmacol Bull; 2003; 37(2):41-9. PubMed ID: 14566213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.